Allstate Corp Purchases Shares of 9,640 Agilent Technologies, Inc. $A

Allstate Corp bought a new position in Agilent Technologies, Inc. (NYSE:A) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 9,640 shares of the medical research company’s stock, valued at approximately $1,237,000.

Several other institutional investors have also recently bought and sold shares of the business. Brighton Jones LLC lifted its position in shares of Agilent Technologies by 6.1% during the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock worth $626,000 after purchasing an additional 270 shares in the last quarter. Jones Financial Companies Lllp boosted its holdings in Agilent Technologies by 15.9% during the first quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock worth $602,000 after purchasing an additional 769 shares during the last quarter. Geneos Wealth Management Inc. increased its position in shares of Agilent Technologies by 54.8% during the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock worth $70,000 after purchasing an additional 212 shares during the last quarter. Acadian Asset Management LLC raised its holdings in shares of Agilent Technologies by 16.5% in the 1st quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock valued at $625,000 after purchasing an additional 758 shares during the period. Finally, Sivia Capital Partners LLC acquired a new stake in Agilent Technologies during the 2nd quarter valued at $273,000.

Agilent Technologies Stock Down 2.8%

Shares of NYSE A opened at $135.74 on Wednesday. The firm’s 50 day simple moving average is $144.00 and its two-hundred day simple moving average is $133.77. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $160.27. The stock has a market capitalization of $38.48 billion, a P/E ratio of 29.70, a PEG ratio of 4.05 and a beta of 1.29.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, beating the consensus estimate of $1.58 by $0.01. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The firm had revenue of $1.86 billion during the quarter, compared to the consensus estimate of $1.83 billion. During the same quarter in the previous year, the company posted $1.46 earnings per share. The business’s revenue was up 9.4% on a year-over-year basis. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. As a group, analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 28th. Investors of record on Tuesday, January 6th will be given a dividend of $0.255 per share. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.25. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Tuesday, January 6th. Agilent Technologies’s dividend payout ratio is presently 22.32%.

Analysts Set New Price Targets

A number of analysts have issued reports on A shares. Rothschild & Co Redburn started coverage on shares of Agilent Technologies in a report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 price objective for the company. Wells Fargo & Company increased their target price on shares of Agilent Technologies from $150.00 to $175.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Evercore ISI raised shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and lifted their price target for the company from $155.00 to $160.00 in a research note on Monday, January 5th. Rothschild Redb upgraded shares of Agilent Technologies to a “strong-buy” rating in a report on Wednesday, October 8th. Finally, The Goldman Sachs Group started coverage on Agilent Technologies in a report on Tuesday, December 9th. They set a “buy” rating and a $170.00 price target on the stock. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $164.50.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, VP Rodney Gonsalves sold 3,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total transaction of $464,970.00. Following the transaction, the vice president owned 31,846 shares in the company, valued at approximately $4,935,811.54. This represents a 8.61% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Padraig Mcdonnell sold 12,490 shares of the firm’s stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $150.00, for a total value of $1,873,500.00. Following the completion of the transaction, the chief executive officer owned 33,448 shares of the company’s stock, valued at approximately $5,017,200. The trade was a 27.19% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 16,401 shares of company stock valued at $2,468,962.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.